UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 837

Sortiert nach

The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase

Oncogene, 2015-07, Vol.34 (27), p.3556-3567

2015

Link zum Volltext

Verfügbarkeit prüfen

A novel interaction between HER2 neu and cyclin E in breast cancer

Oncogene, 2010-07, Vol.29 (27), p.3896-3907

2010

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

Nature medicine, 1997-04, Vol.3 (4), p.429-436

1997

Link zum Volltext

Verfügbarkeit prüfen

Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study

Intensive care medicine, 2017-12, Vol.43 (12), p.1808-1819

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange in the intensive care unit: a narrative review

Intensive care medicine, 2022-10, Vol.48 (10), p.1382-1396

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3198-3208

2004

Link zum Volltext

Verfügbarkeit prüfen

P5-03-03: Identification of New Substrates for Breast Tumor Specific Low-Molecular-Weight Cyclin E Cyclin-Dependent-Kinase 2

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-03-03

2011

Link zum Volltext

Verfügbarkeit prüfen

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics

Annals of internal medicine, 2021-09, Vol.174 (9), p.1293

2021

Link zum Volltext

Verfügbarkeit prüfen

Cyclin E and Its Low Molecular Weight Forms in Human Cancer and as Targets for Cancer Therapy

Cancer biology & therapy, 2003-07, Vol.2 (4 Suppl 1), p.37-46

2003

Link zum Volltext

Verfügbarkeit prüfen

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome

Breast cancer research : BCR, 2004-01, Vol.6 (5), p.188-191, Article 188

2004

Link zum Volltext

Verfügbarkeit prüfen

Retrovirus-Mediated Enzymatic Correction of Tay-Sachs Defect in Transduced and Non-Transduced Cells

Human molecular genetics, 1998-05, Vol.7 (5), p.831-838

1998

Link zum Volltext

Verfügbarkeit prüfen

Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer

Gene therapy, 1996-09, Vol.3 (9), p.769

1996

Link zum Volltext

Verfügbarkeit prüfen

A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease

The Journal of biological chemistry, 1990-05, Vol.265 (13), p.7324-7330

1990

Link zum Volltext

Verfügbarkeit prüfen

Targeting the cell cycle for prognosis and therapy of breast cancer

Breast cancer research : BCR, 2005-01, Vol.7 (S2), p.S-S, Article S.24

2005

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events

Circulation. Cardiovascular interventions, 2018-03, Vol.11 (3), p.e005841-e005841

2018

Link zum Volltext

Verfügbarkeit prüfen

Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease

Mammalian genome, 1995-12, Vol.6 (12), p.844-849

1995

Link zum Volltext

Verfügbarkeit prüfen

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype

Breast diseases, 2009-01, Vol.20 (1), p.64-65

2009

Link zum Volltext

Verfügbarkeit prüfen

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype: Voduc D, Nielsen TO, Cheang MC, et al (British Columbia Cancer Agency, Vancouver, Canada; Univ of British Columbia, Vancouver, Canada; et al) Hum Pathol 39:1431-1437, 2008

Breast diseases, 2009, Vol.20 (1), p.64-65

2009

Link zum Volltext

Verfügbarkeit prüfen

CDK2 is required for LMW-cyclin E mediated murine mammary tumorigenesis

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2007

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular epidemiology of Tay-Sachs disease in Europe

Biomedicine & pharmacotherapy, 1994, Vol.48 (8), p.341-346

1994

Link zum Volltext

Verfügbarkeit prüfen

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise

Nature medicine, 2010-09, Vol.16 (9), p.981-989

2010

Link zum Volltext

Verfügbarkeit prüfen

Ten novel mutations in the HEXA gene in non-Jewish Tay — Sachs patients

Human molecular genetics, 1993-01, Vol.2 (1), p.61-67

1993

Link zum Volltext

Verfügbarkeit prüfen

Transfer of a foreign gene into the brain using adenovirus vectors

Nature genetics, 1993-03, Vol.3 (3), p.224-228

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 837

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(664)
Mit Volltextzugriff
(742)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase

A novel interaction between HER2 neu and cyclin E in breast cancer

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study

Plasma exchange in the intensive care unit: a narrative review

Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer

P5-03-03: Identification of New Substrates for Breast Tumor Specific Low-Molecular-Weight Cyclin E Cyclin-Dependent-Kinase 2

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics

Cyclin E and Its Low Molecular Weight Forms in Human Cancer and as Targets for Cancer Therapy

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome

Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study

Retrovirus-Mediated Enzymatic Correction of Tay-Sachs Defect in Transduced and Non-Transduced Cells

Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer

A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease

Targeting the cell cycle for prognosis and therapy of breast cancer

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events

Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype

CDK2 is required for LMW-cyclin E mediated murine mammary tumorigenesis

Molecular epidemiology of Tay-Sachs disease in Europe

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise

Ten novel mutations in the HEXA gene in non-Jewish Tay — Sachs patients

Transfer of a foreign gene into the brain using adenovirus vectors

Suchergebnisse filtern